General MedicationsOPHTHALMICStandard
TRYPTYR
ACOLTREMON
Standard Dose
0.003%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TRYPTYR is listed in Drugs@FDA under application 217370 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ACOLTREMON Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.003% Sponsor ALCON LABS INC Submission history Latest submission status date: 2025-05-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRYPTYR is listed in Drugs@FDA under application 217370 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ACOLTREMON Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.003% Sponsor ALCON LABS INC Submission history Latest submission status date: 2025-05-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.